Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00443716 · ClinicalTrials.gov registry record · NA
Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00443716: Completed NA study, sponsored by Mayo Clinic.
NCT00443716 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00443716, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
To evaluate the effect of estrogen treatment on adipocytic and osteoblastic parameters by histomorphometrically measuring adipocyte volume (AV/TV) and adipocyte numbers in goldner's stained iliac crest bone biopsy specimens collected from subjects recruited in the study (IRB number 21B85). The adipocytic parameters will be then correlated with osteoblastic parameters obtained previously during the course of the initai study involving the effect of transdermal estrogen on bone turnover in postmenopausal osteoporotic women.
Interventions
- DRUG estrogen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 1985-04 |
| Est. Completion | 1989-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00443716
The ClinicalTrials.gov registry entry for NCT00443716 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which estrogen is the first listed.
NCT00443716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00443716 about?
NCT00443716 is a clinical study titled "Determination of Adipocyte Parameters in Iliac Crest Biopsies From Post Menopausal Women". To evaluate the effect of estrogen treatment on adipocytic and osteoblastic parameters by histomorphometrically measuring adipocyte volume (AV/TV) and adipocyte numbers in goldner's stained iliac crest bone biopsy specimens collected from subjects recruited in the study (IRB number 21B85). The adipo...
What is the current status of trial NCT00443716?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 1985-04. Estimated completion is 1989-04.
What interventions are being tested in trial NCT00443716?
The interventions under investigation include: estrogen (DRUG).
Who is sponsoring clinical trial NCT00443716?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.